Description
Small cell lung cancer (SCLC) is an incredibly aggressive form of lung cancer with limited treatment options, begging the need for major
therapeutic breakthroughs in order to increase poor (less than 7%) survival rates of patients. This project will take advantage of our state-of-the-art experimental model systems to provide robust preclinical evidence for the use of NK cell immunotherapy in the treatment of SCLC primary and metastatic disease
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
Small cell lung cancer, metastases, natural killer cells, tumour immunology, mouse models
School
Biomedicine Discovery Institute (School of Biomedical Sciences) » Biochemistry and Molecular Biology
Available options
PhD/Doctorate
Time commitment
Full-time
Part-time
Top-up scholarship funding available
No
Physical location
15 Innovation Walk
Research webpage